i) Recognition: P1-dibenzocyclooctyne (DBCO) specifically recognized renal cancer cells by targeting carbonic anhydrase IX (CAIX) which was abundantly expressed in RCC and almost no expression in healthy tissues. Here, CA9 is linked to renal carcinoma.